)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Lexeo Therapeutics
Lexeo Therapeutics (LXEO) investor relations material
Lexeo Therapeutics Fireside chat summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Fireside chat summary29 Jun, 2026
Introduction and agenda
Discussion focused on the phase III program for FACM, regulatory strategy, pivotal study design, and patient selection, with additional updates on PKP2 and financial outlook.
Background and experience of the speaker
Lexeo Therapeutics specializes in cardiac genetic medicines, with advanced programs targeting Friedreich's ataxia and PKP2-related diseases.
Current industry trends
Regulatory agencies, particularly CBER, are showing increased openness and flexibility toward rare disease gene therapies, with ongoing discussions involving multiple companies.
The competitive landscape in FA is evolving, with complementary approaches emerging for cardiac and neurologic disease components.
Rationale for 15% LVMI reduction target
NSVT as surrogate vs clinical endpoint for PKP2
Sequential dosing potential for LX2006 and CNS
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Lexeo Therapeutics
- LX1001 showed dose-dependent APOE2 expression, reduced tau, and no ARIA in APOE4 Alzheimer's.LXEO
Study Update8 Jul 2026 - Gene therapy pipeline shows strong interim efficacy and safety, with major data readouts due in 2025.LXEOPiper Sandler 36th Annual Healthcare Conference8 Jul 2026
- Multiple gene therapy programs near key data readouts, targeting major cardiac and CNS diseases.LXEOChardan's 8th Annual Genetic Medicines Conference8 Jul 2026
- Gene therapies for cardiac diseases show strong safety, efficacy, and regulatory progress.LXEOJ.P. Morgan Biotech: CEO Fireside Series – Lexeo Therapeutics (LXEO)8 Jul 2026
- LX2006 shows robust safety and sustained cardiac biomarker improvements in FA cardiomyopathy.LXEOStudy Update8 Jul 2026
- Directors and auditor ratified; no stockholder questions submitted.LXEOAGM 202625 Jun 2026
- Gene therapies for rare cardiac diseases advance with strong clinical data and key milestones ahead.LXEOCorporate presentation16 Jun 2026
- Pivotal LX2006 trial in FA set for Q2 2026, targeting accelerated approval and BLA in 2028.LXEOInvestor update15 Jun 2026
- Pivotal gene therapy studies advance with robust efficacy, regulatory progress, and strong safety data.LXEORBC Capital Markets Global Healthcare Conference 202622 May 2026
Next Lexeo Therapeutics earnings date
Q2 202610 Aug, 2026
Lexeo Therapeutics
Next Lexeo Therapeutics earnings date
Q2 202610 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage